FDA panel backs first-of-its-kind flu vaccine using mRNA technology

Дата публикации: 18-06-2026 20:11:18

WASHINGTON (AP) — A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of the first made with the same mRNA technology that was key to ending the COVID-19 pandemic. The Food and Drug Administration is evaluating Moderna's new shot, dubbed mFlusiva, for older [...]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	FDA panel backs first-of-its-kind flu vaccine using mRNA technology	0	7	18-06-2026
2	New Kind of Flu Shot Is on the Way as FDA Approves Moderna’s mRNA-Based Vaccine	0	10.21	06-08-2026
3	The FDA Approved a New mRNA Flu Vaccine. Here’s What to Know	0	10.12	10-08-2026
4	FDA Approves mFLUSIVA (influenza vaccine, mRNA) for the Prevention of Seasonal Influenza	0	10.86	05-08-2026
5	Отечественную гриппозную вакцину "Флю-М" смогут применять для детей и пожилых	0	0	04-02-2021
6	23 ФЕВРАЛЯ 1915 ГОДА – 110 лет назад – РОДИЛАСЬ ...	0	0	24-02-2025
7	¿Cadenas o neumáticos de invierno? La guía definitiva	0	0	22-01-2025
8	What I Learned in 3 Years of Writing a Newsletter	0	0	14-02-2021
9	Hantavirus vaccine exists but is ineffective in person-to-person transmission	0	9.82	14-05-2026
10	Qantas Launches India Service With Sydney-Delhi Route	0	0	06-12-2021

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: www.newsnationnow.com.